SciELO - Scientific Electronic Library Online

 
vol.34 número3Obesidade abdominal dinapênica e atividades de lazer em indivíduos em hemodiáliseEletromiografia em sujeitos com esclerose lateral amiotrófica e disfagia: estudo transversal índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Compartir


Journal of Human Growth and Development

versión impresa ISSN 0104-1282versión On-line ISSN 2175-3598

J. Hum. Growth Dev. vol.34 no.3 Santo André  2024  Epub 11-Abr-2025

https://doi.org/10.36311/jhgd.v34.15873 

ORIGINAL ARTICLE

Chronic kidney disease-mineral and bone disorder in individuals on hemodialysis and its correlations with clinical, anthropometric and laboratory conditions

Fernanda Zobole Peterlea  , participated in data collection, data analysis, statistical analysis and writing of the text

Cleodice Alves Martinsb  , participated in the study design, data analysis, statistical analysis and final version of the text

Edson Theodoro Dos Santos Netoc  , participated in the general orientation of the study and relevant critical review of the intellectual content and final approval of the text to be published

Luciane Bresciani Salarolid    , participated in the design, general orientation of the study, study design, statistical analysis, relevant critical review of the intellectual content and final approval of the text to be published

aPrograma de Pós-Graduação em Nutrição e Saúde, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil

bPrograma de Pós-Graduação em Nutrição e Saúde, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil

cDepartamento de Saúde Pública, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil

dPrograma de Pós-Graduação em Nutrição e Saúde, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil e Departamento de Saúde Pública, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil

Programa de Pós-Graduação em Nutrição e Saúde, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil e Departamento de Saúde Pública, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo (UFES), Vitória, Espírito Santo, Brasil


Authors summary

Why was this study done?

Chronic kidney disease is one of the main global chronic comorbidities, with bone mineral disease standing out as one of its most frequent complications, generating extremely serious and fatal outcomes in individuals undergoing hemodialysis therapy. The integrated analysis of clinical, nutritional and laboratory conditions in this scenario is extremely important to understand these correlations and served as a strategy for the development of this study.

What did the researchers do and find?

This is a cross-sectional study conducted in 11 hemodialysis centers, with a final population of 790 individuals, in southeastern Brazil. Mineral and bone disease in chronic kidney disease was assessed according to specific laboratory diagnostic criteria already defined in the literature. We highlight the following strongest correlations: vitamin D levels had a strong positive correlation with adductor pollicis muscle thickness and a strongly negative correlation with waist circumference and arm muscle area; in addition, laboratory values of ionic calcium had a strong positive correlation with hemodialysis time and a strong negative correlation with body mass index.

What do these findings mean?

The results obtained confirm the proximity of these conditions in clinical practice, emphasizing the comprehensive understanding of mineral and bone disease in chronic kidney disease in hemodialysis individuals. This is essential for the accurate identification of this individual and the formulation of more effective intervention strategies, enabling more assertive action in the prevention and treatment of problems related to this clinical condition, justified and guided by scientific evidence.

Keywords Chronic kidney disease; mineral and bone disorder in chronic kidney disease; kidney dialysis and nutritional status

Abstract

Introduction:

Chronic Kidney Disease-Mineral and Bone Disease is one of the main complications of individuals on hemodialysis.

Objective:

this research aims to analyze the correlations of the laboratory components of Chronic Kidney Disease-Mineral and Bone Disease with clinical, anthropometric and laboratory factors of individuals on hemodialysis.

Methods:

this is a cross-sectional study with 790 patients on hemodialysis, in southeastern Brazil. Chronic Kidney Disease- Mineral and Bone Disease was evaluated according to specific laboratory diagnostic criteria already defined in the literature. Assessment was carried out regarding the existence of a linear correlation between the dependent and independent variables. References used: r < 0.4 (weak correlation); r ≥ 0.4 and < 0.6 (moderate correlation); r ≥ 0.6 (strong correlation). The Significance level adopted was 5%.

Results:

parathyroid hormone and duration of renal replacement therapy showed a moderate positive correlation with each other (r 0.582, p <0.001). Phosphorus levels had a moderate positive correlation with potassium (r 0.556, p 0.020) and negative correlation with age (r -0.413, p 0.036). 25-hydroxyvitamin D levels had a positive correlation with adductor pollicis muscle thickness (r 0.602, p 0.018) and right hand grip strength (r 0.402, p <0.001), and a negative correlation with tricipital skinfold (r -0.600, p 0.020) and corrected arm muscle area (r -0.769, p 0.024). Ionic calcium levels had a strong positive correlation with duration of renal replacement therapy (r 0.961, p 0.015) and a strong negative correlation with Body Mass Index (r -0.82, p 0.046).

Conclusion:

all laboratory elements of Chronic Kidney Disease- Mineral and Bone Disease showed important correlations with clinical, anthropometric and laboratory components of individuals on hemodialysis.

Keywords Chronic kidney disease; mineral and bone disorder in chronic kidney disease; kidney dialysis and nutritional status

Highlights

It is noteworthy that all laboratory components of mineral and bone disease in chronic kidney disease in individuals on hemodialysis in the population analyzed showed some degree of correlation with the clinical, laboratory and anthropometric conditions studied. Several strongly positive or negative correlations were evident.

Keywords Chronic kidney disease; mineral and bone disorder in chronic kidney disease; kidney dialysis and nutritional status

Síntese dos autores

Por que este estudo foi feito?

A doença renal crônica é uma das principais comorbidades crônicas globais, com a doença mineral óssea destacando-se como uma de suas complicações mais frequentes, gerando desfechos extremamente graves e fatais em indivíduos submetidos à terapia de hemodiálise. A análise integrada de condições clínicas, nutricionais e laboratoriais neste cenário é de extrema importância para entendimento dessas correlações e serviu como estratégia para o desenvolvimento deste estudo

O que os pesquisadores fizeram e encontraram?

Este é um estudo transversal, realizado em 11 centros de hemodiálise, apresentando como população final 790 indivíduos, no sudeste do Brasil. A doença mineral e óssea da doença renal crônica foi avaliada conforme critérios diagnósticos laboratoriais específicos já definidos pela literatura. Destacamos as seguintes correlações mais fortes: níveis de vitamina D tiveram correlação positiva forte com espessura do músculo adutor do polegar e correlação fortemente negativa com perímetro da cintura e área muscular do braço; além de valores laboratoriais do cálcio iônico que teve forte correlação positiva com tempo de hemodiálise e forte correlação negativa com índice de massa corpórea.

O que essas descobertas significam?

Os resultados obtidos ratificam a proximidade destas condições na prática clínica, enfatizando o entendimento abrangente da doença mineral e óssea na doença renal crônica em indivíduos hemodialíticos. Esta compreensão é essencial para a identificação precisa desse indivíduo e a formulação de estratégias de intervenção mais eficazes. Possibilitando uma atuação mais assertiva na prevenção e tratamento dos agravos relacionados a esta condição clínica, de forma justificada e norteada por evidências científicas. Estes achados indicam que todos os parâmetros laboratoriais da doença mineral e óssea da doença renal crônica, apresentam correlações com fatores clínicos, antropométricos ou laboratoriais observados em indivíduos submetidos à hemodiálise. Assim, a atenção a tais correlações, direciona a seleção de estratégias terapêuticas, preventivas e prognósticas para essa população no ambiente clínico.

Palavras-chave: doença renal crônica; distúrbio mineral e ósseo na doença renal crônica; diálise renal e estado nutricional

Resumo

Introdução:

a Doença Mineral e Óssea da Doença Renal Crônica é uma das principais complicações dos indivíduos em hemodiálise provavelmente correlacionada com vários aspectos clínicos.

Objetivo:

analisar as correlações dos componentes laboratoriais da Doença Mineral e Óssea da Doença Renal Crônica com fatores clínicos, antropométricos e laboratoriais de indivíduos em hemodiálise.

Método:

estudo transversal com 790 indivíduos em hemodiálise no sudeste do Brasil. A Doença Mineral e Óssea da Doença Renal Crônica foi avaliada conforme critérios diagnósticos laboratoriais específicos já definidos pela literatura. Realizada avaliação quanto à existência de correlação linear entre as variáveis dependentes e independentes. Utilizado: r < 0,4 (correlação fraca); r ≥ 0,4 e < 0,6 (correlação moderada); r ≥ 0,6 (correlação forte). Nível de significância adotado de 5%.

Resultados:

o paratormônio e tempo de terapia renal substitutiva apresentaram correlação positiva moderada entre si (r = 0,582, p <0,001). Níveis de fósforo teve correlação positiva moderada com potássio (r = 0,556, p 0,020) e negativa com a idade (r = -0,413, p 0,036). Valores de vitamina D tiveram correlação positiva com espessura do músculo adutor do polegar (r = 0,602, p 0,018) e força de preensão palmar à direita (r = 0,402, p <0,001), e correlação negativa com prega cutânea tricipital (r = -0,600, p 0,020) e área muscular do braço corrigida (r = - 0,769, p 0,024). Índices de cálcio iônico tiveram forte correlação positiva com o tempo de terapia renal substitutiva, (r= 0,961, p 0,015) e forte correlação negativa com índice de massa corporal (r = -0,82, p 0,046).

Conclusão:

todos os elementos laboratoriais da Doença Mineral e Óssea da Doença Renal Crônica apresentaram correlações importantes com componentes clínicos, antropométricos e laboratoriais dos indivíduos em hemodiálise, contribuindo para melhor abordagem deste contexto clínico e condutas mais assertivas.

Palavras-chave: doença renal crônica; distúrbio mineral e ósseo na doença renal crônica; diálise renal e estado nutricional

Highlights

Destaca-se que todos os componentes laboratoriais da doença mineral e óssea da doença renal crônica, em indivíduos em hemodiálise da população analisada, apresentaram algum grau de correlação com as condições clínicas, laboratoriais e antropométricas estudadas. Sendo evidenciadas várias correlações fortemente positivas ou negativas.

Palavras-chave: doença renal crônica; distúrbio mineral e ósseo na doença renal crônica; diálise renal e estado nutricional

INTRODUCTION

Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) is one of the most common complications of patients undergoing hemodialysis, and is defined, among other criteria, as the involvement of specific changes in biochemical markers such as calcium, phosphorus, parathyroid hormone (PTH) and vitamin D1,2,3. Changes in these mineral and bone parameters, associated with nutritional changes in patients on hemodialysis, are often associated with relevant adverse outcomes, mainly due to vascular calcification4,5. The development of models to predict these combinations and optimize the management of these patients may play a crucial role in this context1.

Body composition is commonly modified in individuals with Chronic Kidney Disease (CKD), characterized by the coexistence of obesity and muscle loss, which may even occur concomitantly6. The laboratory components of CKD-MBD have a significant influence on the nutritional status of these individuals4,5,6,7. In the context of hemodialysis, body composition may also reveal different aspects of the patient, such as food intake, hormonal levels, physiological aspects of the CKD stage, as well as the impact of the renal replacement therapy (RRT) modality8. Therefore, understanding the relationship between body components and the specific characteristics of these patients represents a significant challenge.

Changes in the levels of phosphorus, PTH, calcium and vitamin D play very relevant roles in the scenario and development of CKD-MBD. All of them, with their own physiological functions, will contribute differently to the metabolism of these individuals9. Some of the implications include the induction of the conversion of white adipose tissue into brown adipose tissue by PTH, the association of vitamin D with bone homeostasis, calcium deposition in soft tissues, and the increase in cardiovascular mortality associated with uncontrolled phosphorus10,11,12,13.

According to the Kidney Disease Improving Global Outcomes (KDIGO) guidelines, the management of CKD-MBD, among other therapeutic strategies, should include sequential assessments of the serum levels of these elements. This is justified because mineral and bone metabolism disorders in this population have unique characteristics and may be potentially modifiable2,5,14. Nutritional assessment is also recommended by KDIGO, but there is still limited evidence on the recommended tool, assertively, with low cost and good clinical replicability2,15. Thus, we expanded the understanding of these patients by considering their correlations with clinical, anthropometric and laboratory aspects within the CKD-MBD scenario.

In face of these considerations, the objective of this study is to analyze the correlations of the laboratory components of CKD-MBD with clinical, anthropometric and laboratory factors of patients on hemodialysis.

METHODS

Study design

This is a cross-sectional epidemiological study.

Place and period of study

The study was conducted from February to September 2019 in 11 hemodialysis centers in the Geater Vitoria region, Espírito Santo, Brazil.

Study population and eligibility criteria

Initially, 1,416 patients were included. The exclusion criteria were: who were on respiratory or on contact precautions, hospitalized, transferred to another hemodialysis unit and individuals with limitations in answering the questionnaire. The total was 1,047 eligible people, with a refusal rate of 2.2% (n = 23) and 234 with missing data in the medical record; the final population studied was 790 patients. The population participating in this research was composed of individuals over 18 years of age, who had a confirmed diagnosis of CKD according to the International Classification of Diseases, version 10 (ICD-10), and who had been undergoing HD in the public network, philanthropic networks, hospitals and private clinics in the region mentioned, for more than 3 months, and signed the Informed Consent Form.

Data collection

The anthropometry was carried out after the hemodialysis sessions, by trained professionals, using standardized equipment; the measurements were carried out three times and their arithmetic mean was obtained. The individuals were barefoot, in an upright position with feet together, with as little clothing as possible, arms extended along the body and staring, to measure body mass, height and other measurements15.

The anthropometric data evaluated were: body mass index (BMI) obtained by kg/m2 and classified by the WHO16; adductor pollicis muscle thickness (APMT) was measured with the aid of an adipometer (Lange®) exerting continuous pressure, compressing the adductor muscle at the apex of the angle between thumb and index finger on the dominant hand17 and subsequently classified18; corrected arm muscle area (CAMA) was obtained from the values of arm circumference and triceps skinfold15 being classified after19; tricipital skinfold (TSF) was measured on the back of the arm using an adipometer15; hand grip strength (HGS) was performed on the participant’s dominant upper limb or with the hand without an arteriovenous fistula, using the Jamar® 12-0600 dynamometer20 and classified using the cutoff point of 27 kg for men and 16 kg for women21.

Age was viewed directly in the medical record and stratified into up to 59 years and 60 years old or more. The duration of hemodialysis was asked directly to the patients and categorized in years and classified as follows: “0 to 2 years”, “3 to 5 years”, “6 to 10 years” and “more than 10 years”. The sex category was self-declared. Laboratory samples were collected as routine by the clinics, and the data collected from the individuals’ clinical records during the period studied were subsequently classified according to the literature22,23.

Statistical analysis

In the statistical analysis, for the descriptive evaluation, the variables were presented as middle of median, average, standard deviation, minimum and maximum. The normality of the variables was assessed using the Shapiro Wilk test and the Mann-Whitney test was performed to compare the medians, and the Student’s T test was used to compare the means. In order to assess the existence of a linear correlation between the independent and dependent variables, the Pearson correlation test was performed for the normal distribution, and the Spearman correlation test for the non-parametric distribution of the variables. Thus, r < 0.4 (weak correlation); r ≥ 0.4 and < 0.6 (moderate correlation); r ≥ 0.6 (strong correlation). All analyses were carried out using R software (4.2.2) for Windows. The significance level adopted was 5%.

Ethical and legal aspects of research

The research work was approved by the Research Ethics Committee (Comitê de Ética em Pesquisa - CEP) of the Federal University of Espírito Santo (Universidade Federal do Espírito Santo - UFES) with registration number 2.104.942 and CAAE 68528817.4.0000.5060 and all participants signed the informed consent form.

RESULTS

Tables 1 and 2 present the other descriptive characteristics of the anthropometric, clinical and laboratory variables grouped by sex of the studied population. As evidenced in table 1, the study consisted of 790 patients on hemodialysis (HD) with an average (SD) age of 54.23 years old (SD+14.68), 42% are female, also noteworthy is the RRT time of 5.68 years (SD+5.75) in men and 5.51 years old (SD +4.67) in women, respectively.

TABLE 1 Descriptive table of clinical and anthropometric variables grouped by sex 

Sex Variable Age (years) Time on HD (years Weight (Kg) BMI (Kg/m2) TSF (mm) APMT (mm) R-HGS (kgf) L-HGS (kgf) AC (cm) CAMA (cm2)
N 790 748 788 786 788 789 768 760 788 786
Female (n= 338) Average ± SD 53.2±15.1 5.6±5.7 64.1±14.6 26.1±5.5 22.6±9.3 11.6±3.9 14.0±6.1 11.9±5.6 29.2±5.0 33.4±11.8
Median 55 4 62.5 25.22 22.23 11.3 14 11.96 28.63 31.54
IQR 41 - 64 2 - 7.7 53.2 - 68.7 22.1 - 29.9 18 - 29 9 - 14.6 10 - 18 7 - 15 22 - 35 28.5 - 33
Minimum 20 0 37 14.65 4.3 2.17 0 0 16.66 8.12
Maximum 85 40 122.9 44.5 55.3 24.3 39.6 28.6 46.3 79.0
Male (n=452) Average ± SD 54.9±14.3 5.5±4.6 71.6±14.3 25.4±5.9 15.7±8.7 12.8±4.4 24.5±10.6 19.9±9.7 28.7±4.4 38.9±11.5
Median 57 4 69.9 24.7 14 12.3 24 19.8 28.2 37.8
IQR 45 - 65 2 - 8 61 - 85.7 21.8 - 27.7 8.7 - 20 10 - 15.2 15 - 28.7 13 - 25 23 - 35 34.5 - 49
Minimum 20 0 39 13.6 1.3 3.3 0 0 19 2.1
Maximum 89 24 127.3 94.3 77 29.3 104.7 95.3 80.3 74.4

N = total number; IQR = interquartile range; HD = hemodialysis; BMI = body mass index; TSF= tricipital skinfold; APMT = adductor pollicis muscle thickness; R-HGS = rigth handgrip strength; L-HGS = left handgrip strength; AC= arm circunference; CAMA = corrected arm muscle area; SD = standard deviation.

Table 2 Descriptive table of laboratory variables grouped by sex 

Sex Variable Hb (g/dl) P (mEq/l) K (mEq/l) Alb (g/dl) Ferritin (UI/ml) TSI (%) Leu (/ml) AF (UI/ml) Ca ion mEq/l Vith (ng/ml) PTH (UI/ml)
N 88 79 80 714 326 300 720 723 670 532 727
Female (n=338) Average ± SD 9.3±2.7 5.1±1.1 5.4±0.8 3.7±0.4 233.6±197.4 24.1±12.2 6.7±2.5 251.8±328.6 4.2±0.5 32.8±13.1 762.3±566.0
Median 9 5 5 3.8 168.5 22 6.5 136 4.26 32 535
IQR 8 – 10 4.7 – 6 5 – 6 3.7 – 4 81 – 351 16.5 – 27 5.0 – 8.0 93.5 – 230 4 – 4.75 23 – 42 362 –1027
Minimum 4 2 3.9 2.6 10 6 2.35 48 2.3 7 204
Maximum 20 8 7 7.6 1024 85 28.2 2452 6.14 70 3000
Female (n=338) Average ± SD 10.1±1.7 5.7±2.6 5.6±0.8 3.8±0.6 272.3±369.5 25.0±12.5 6.1±2.0 213.6±271.5 4.2±0.5 34.4±13.0 755.2±532.7
Median 10 5 6 3.9 162 22 5.8 129 4.3 34 560.5
IQR 9 – 11 4 – 7 5 – 6 3.8 – 4 77.5 – 321 16.5 – 29 4 – 7 83 – 203 4 – 4.5 27.7 – 43 354.5 – 974
Minimum 6 3 3 0.9 9 4 2 3.4 2.39 6.4 200
Maximum 14 18 7 13 2848 85 14 2850 6.19 78 2598

N = individuals number; IQR= interquartile range; Hb= hemoglobin; P = phosphorus; K = potassium; Alb = albumin; TSI = transferrin saturation index; Leu = leukocytes; AF = alkaline phosphatase; Ca ion = Calcium ionic; Vit D =vitamin D; PTH = parathyroid hormone; SD = standard deviation.

Still in relation to the variables presented in table 1, the average weight among women was 64.1kg (DP+14,6) and in men 71.6kg (DP+14,3), with a BMI of 26.1kg/m2 (SD+5.5) and 25.4kg/m2 (SD+5.9) respectively. The TSF it was 22.6mm (SD+9.3) in women and 15.7mm (SD+8.7) in men. APMT was 11.6mm (SD+3.9) in females and 12.8mm (SD+4.4) in males. A right HGS it was 14kg (SD+6.1) and 11.9kg (SD+5.6) the left in women and in men right HGS 24.5kg (SD+10.6) and left HGS 19.9kg (SD+9.7). The AC evidenced was 29.2cm (SD+5) in women and 28.7cm (SD+4.4) in men. Concluding table 1, CAMA of 33.4cm2 (SD+11.8) in females and 38.9cm2 (SD+11.5) in males.

Regarding the variables related to CKD-MBD, women had phosphorus 5.19mg/dL (SD+1.19) and men had 5.79mg/dL (SD+2.61), as well as ionic calcium 4.25mg/dL (SD+0.51) and 4.26mg/dL (SD+0.51), vitamin D 32.8mg/dL (SD+13.12) and 34.48mg/dL (SD +13.08) and PTH 762.5mg/dL (SD+566.02) and 755.24mg/ dL (SD+532.73) in that order, as these variables are the determining factors in the definition of CKD-MBD. The laboratory variables were also highlighted: hemoglobin, potassium, albumin, ferritin, transferrin saturation index, leukocytes and alkaline phosphatase, as shown in table 2.

Table 3 shows the correlations between the laboratory variables of CKD-MBD and the clinical, anthropometric and laboratory variables. In this way, the variables with the highest correlations found in the present study stand out. The longer the RRT time, the higher PTH levels (r = 0.582, p = <0.001),the other variables analyzed showed weaker correlations as shown in table 3.

Table 3 Table of correlations between CKD-MBD laboratory variables with clinical, anthropometric and laboratory variables 

Calcium ionic Phosphorus Vitamin D PTH
Age r = 0,10 (IC 95% 0,02 a 0,10) (p = 0,009) * r = -0,41 (IC 95% -0,02 a 0,43) (p = 0,036)* r = -0,14 (IC 95% -0,03 a -0,19) (p = 0,001) * r = -0,21 (IC 95% -0,14 a 0,28) (p < 0,001) *
RRT r = 0,96 (IC 95% 0,02 a 0,16) (p = 0,015) * r = -0,10 (IC 95% -0,03 a 0,40) (p = 0,394) r = 0,13 (IC 95% 0,06 a 0,12) (p = 0,004)* r = 0,58 (IC 95% 0,50 a 0,64) (p = <0,001) *
Weight r = -0,06 (IC 95%-0,01 a 0,02) (p = 0,097) r = 0,13 (IC 95%-0,20 a 0,24) (p = 0,248) r = -0,15 (IC 95% -0,04 a -0,16) (p = <0,001)* r = -0,00 (IC 95% -0,16 a 0,01) (p = 0,954)
BMI r = -0,82 (IC 95% -0,81 a -0,99) (p = 0,046) * r = 0,13 (IC 95% -0,26 a 0,18) (p = 0,703) r = -0,20 (IC 95% -0,03 a -0,31) (p = <0,001)* r = -0,00 (IC 95% -0,00 a 0,01) (p = 0,921)
TSF r = -0,07 (IC 95% -0,13 a 0,02) (p = 0,073) r = 0,13 (IC 95% -0,29 a 0,15) (p = 0,243) r = -0,60 (IC 95% -0,43 a -0,80) (p = 0,020)* r = -0,05 (IC 95% -0,02 a 0,12) (p = 0,094)
APMT r = -0,03 (IC 95%-0,13 a 0,03) (p = 0,391) r = 0,17 (IC 95% -0,08 a 0,35) (p = 0,140) r = 0,60 (IC 95% 0,53 a 0,84) (p = 0,018)* r = 0,04 (IC 95% -0,09 a 0,06) (p = 0,265)
R-HGS r = -0,00 (IC 95%-0,06 a 0,09) (p = 0,97) r = 0,17 (IC 95% -0,14 a 0,30) (p = 0,135) r = 0,402 (IC 95% 0,22 a 0,58) (p = <0,001)* r = -0,017 (IC 95% -0,02 a 0,13) (p = 0,643)
L-HGS r = 0,01 (IC 95% -0,05 A 0,10) (p = 0,740) r = 0,04 (IC 95% -0,12 A 0,32) (p = 0,710) r = 0,12 (IC 95% 0,03 a 0,20) (p = 0,005) * r = -0,03 (IC 95% -0,02 A 0,13) (p = 0,391)
AC r = 0,01 (IC 95% -0,09 a 0,06) (p = 0,954) r = 0,066 (IC 95% -0,52 A 0,54) (p = 0,959) r = -0,252 (IC 95% -0,02 a -0,41) (p = 0,021)* r = 0,024 (IC 95% -0,17 A 0,21) (p = 0,800)
CAMA r = 0,00 (IC 95% -0,04 a 0,11) (p = 0,953) r = 0,18 (IC 95% -0,15 a 0,29) (p = 0,119) r = - 0,77 (IC 95% -0,34 a -0,84) (p = 0,024)* r = -0,00 (IC 95% -0,00 a 0,10) (p = 0,957)
Hemoglobin r = 0,32 (IC 95% 0,11 a 0,32) (p = 0,004) * r = -0,08 (IC 95% -0,68 a 0,65) (p = 0,834) r = 0,28 (IC 95 %0,17 a 0,34) (p = 0,031)* r = 0,01 (IC 95% -0,29 a 0,13) (p = 0,954)
Potassium r = -0,10 (IC 95% -0,43 a 0,01) (p = 0,389) r = 0,56 (IC 95% 0,06 a 0,80) (p = 0,020)* r = 0,26 (IC 95%0,01 a 0,49) (p = 0,054)* r = -0,079 (IC 95% -0,026 A 0,184) (p = 0,493)
Albumin r = 0,48 (IC 95% 0,39 a 0,51) (p < 0,001) * r = -0,06 (IC 95% -0,16 a 0,28) (p = 0,587) r = 0,20 (IC 95% 0,11 a 0,28) (p = <0,001)* r = -0,01 (IC 95%-0,01 a 0,06) (p = 0,790)
Ferritin r = 0,03 (IC 95% -0,18 a 0,10) (p = 0,635) r = -0,22 (IC 95% -0,46 a 0,15) (p = 0,172) r = -0,05 (IC 95% -0,18 a 0,08) (p = 0,437) r = -0,07 (IC 95% -0,00 a 0,08) (p = 0,197)
TSI r = 0,01 (IC 95% -0,15 a 0,10) (p = 0,872) r = -0,11 (IC 95% -0,54 a 0,14) (p = 0,567) r = -0,05 (IC 95% -0,09 a 0,19) (p = 0,910) r = 0,034 (IC 95% -0,01 a 0,09) (p = 0,571)
Leukocytes r = 0,06 (IC 95%-0,04 a 0,11) (p = 0,132) r = 0,11 (IC 95% -0,12 a 0,34) (p = 0,331) r = -0,03 (IC 95%-0,06 a 0,12) (p = 0,474) r = 0,06 (IC 95% 0,01 a 0,14) (p = 0,013) *
AF r = 0,07 (IC 95%-0,02 a 0,13) (p = 0,061) r = -0,20 (IC 95% -0,32 a 0,13) (p = 0,091) r = -0,08 (IC 95% -0,01 a -0,18) (p = 0,072) r = 0,54 (IC 95% 0,49 a 0,59) (p <0,001) *
Calciumionic - r = -0,186 (IC 95% -0,360 a 0,097) (p = 0,019) * r = 0,194 (IC 95% 0,110 a 0,278) (p<0,001)* r = 0,057 (IC 95% 0,002 a 0,153) (p = 0,138)
Phosphorus r = -0,186 (IC 95% -0,360 a 0,097) (p = 0,119) - r = -0,178 (IC 95% -0,437 a 0,108) (p = 0,220) r = 0,169 (IC 95% -0,261 a 0,185) (p = 0,141)
Vitamin D r = 0,19 (IC 95%0,11 a 0,27) (p = <0,001) * r = -0,14 (IC 95% -0,44 a 0,11) (p = 0,330) - r = -0,04 (IC 95% -0,01 a 0,03) (p = 0,406)
PTH r = 0,06 (IC 95% 0,00 a 0,15) (p = 0,138) r = 0,17 (IC 95% -0,26 a 0,19) (p = 0,141) r = -0,04 (IC 95% -0,03 a -0,14) (p= 0,228) -

RRT = renal replacement therapy; BMI = Body mass index; TSF = tricipital skinfold; APMT = adductor pollicis muscle thickness; R-HGS = right handgrip strength; L-HGS = left handgrip strength; AC= arm circunference; CAMA = corrected arm muscle area; TSI = transferrin saturation index; AF= alkaline phosphatase; PTH = parathyroid hormone; SD standard deviation. *correlation with statistical significance.

Regarding phosphorus levels, the younger the patient’s age, the higher laboratory phosphorus levels (r = -0.413, p = 0.036). Potassium values (r = 0.556, p = 0.020) showed a moderate positive correlation in relation to phosphorus. The other variables showed weak correlations.

Regarding vitamin D concentrations, a positive correlation was observed in the variables: APMT (r = 0.602, p = 0.018) and R-HGS (r = 0.402, p = <0.001). Negative correlation with TSF (r = -0.600, p = 0.020) and CAMA (r = - 0.769, p = 0.024), therefore, the higher the values of these anthropometric markers, the lower the vitamin D levels. Likewise, the other variables showed weak correlations.

In general, patients who had higher ionic calcium levels had longer RRT time, due to the strong positive correlation (r= 0.961, p = 0.015). Conversely, the lower the ionic calcium levels, the higher the BMI (r = -0.82, p = 0.046), with a strong negative correlation.Age, weight, TSF, APMT, right HGS, left HGS, AC, CAMA, hemoglobin, potassium, albumin, ferritin, transferrin saturation index, leukocytes, alkaline phosphatase, phosphorus, vitamin D and PTH, showed weaker correlations in relation to ionic calcium, according to table 3.

DISCUSSION

The main findings of this study showed significant correlations between the laboratory variables involved in the diagnosis of CKD-MBD and the clinical, anthropometric and laboratory characteristics of individuals undergoing hemodialysis. In summary, the study revealed that laboratory PTH and serum calcium levels positively correlate with the duration of renal replacement therapy. A negative correlation was observed between calcium levels and BMI values of individuals on hemodialysis. Furthermore, laboratory values for phosphorus showed a positive correlation with potassium and a negative correlation with the age of individuals. In conclusion, vitamin D concentration levels indicated a strong positive correlation with APMT and a moderate correlation with R-HGS, and a strong negative correlation with TSF and CAMA.

The results of this study with a population on hemodialysis within the national territory indicate that serum PTH levels increase progressively over the time the individual is undergoing this modality of renal replacement therapy, as evidenced by a moderately significant positive correlation. This association is consistent with the evidence found in the literature in general1,24,25. The increase in PTH may result in consequences such as increased bone remodeling in an erroneous and disordered way, as well as cardiac changes, which in general are evidenced mainly in people with longer periods of time on hemodialysis25.

In a cohort involving 107,299 people, it was observed that younger individuals undergoing hemodialysis had higher phosphorus levels1. These findings were corroborated by the present study, which identified this negative correlation between serum phosphorus levels and the age of people, which may be attributed to a lower phosphate intake among older patients, as well as the tendency to decrease of bone remodeling with advancing age26. Still in relation to serum phosphorus levels, this showed a moderate positive correlation with potassium levels. This phenomenon may be explained by the excessive consumption of foods rich in phosphorus, calcium, sodium and potassium in the diet, portraying contemporary eating patterns that may be understood as barriers to complying with the dietary recommendations established in the literature in this population27,28,29.

The vitamin D which at adequate levels in the body is referenced in the literature as triggering favorable effects on muscles, showed in the present study a positive correlation with APMT and R-HGS30,31. A particularly important tool as a determinant of muscle strength is HGS, mainly because it is not directly influenced by hydration status, but there is scarce data in the CKD population, especially in individuals undergoing chronic hemodialysis31,32. Regarding R-HGS, previous studies demonstrated an association between serum vitamin D level and HGS in patients undergoing hemodialysis, independently of nutritional status30. Another tool also suggested in the literature as a marker for nutritional status is APMT, which may predict handgrip strength in individuals undergoing hemodialysis32,33. In this same scenario, a strongly positive correlation was also identified between vitamin D and APMT.

Still regarding vitamin D and this study findings, a strong negative correlation was evidenced with TSF and CAMA. Obesity has been reported as a common nutritional disorder in the hemodialysis population34. The inverse association between serum vitamin D levels and obesity has been widely documented in several studies, using various anthropometric tools. One of the hypotheses for this association is the sequestration of vitamin D by adipose tissue35,36. There are few studies analyzing vitamin D levels and obesity in a CKD population undergoing hemodialysis, but this is consistent with our findings in patients with higher TSF and CAMA37.

Patients on hemodialysis frequently develop arterial calcifications, which are generally associated with excess of body calcium content. The use of dialysate solutions with calcium concentrations above 2.5mEq/l may be a contributing factor to a positive calcium balance in these people, which results in this condition38. This study identified a strong positive association between serum ionic calcium levels and the duration of renal replacement therapy. The literature also reinforces that maintaining a balance in serum calcium levels is very complex in the dialysis population and studies reinforce the multiple interaction between calcium consumption, vitamin D supplementation and calcium content in the dialysate38,39.

Regarding the strongly negative correlation found in the study between higher BMI and lower ionic calcium levels, we may only speculate that obese people on hemodialysis have been associated with higher concentrations of PTH, perhaps due to their own nutritional status37.

Some of the variables analyzed showed weak correlations with the laboratory components of CKD- MBD, as shown in table 3. This weak relationship suggests a low or even non-existent linear association between the variables, which can be interpreted in different ways in the literature. One possible explanation would be the interference of factors not considered in the results, indicating the need for further in-depth analysis to better understand these interactions. In addition, other methodological approaches may be required to explore possible non-linear or weak relationships.

Understanding the correlations between laboratory elements of CKD-MBD and anthropometric, clinical and laboratory conditions in this study emphasizes the unprecedented nature of the research, reinforced by the scenario of the possibility of early and assertive intervention in this population. As it is a cross-sectional observational study, there are limitations; therefore, causality may not be inferred directly. The study was carried out in a geographic area that covers the metropolitan region of a large capital in the Southeast region and may be expanded to other geographic areas. Besides, the population is similar to other populations, therefore, the findings may be extrapolated.

Our analyses strengthen the recommendations of the NFK-KDOQI guidelines, regarding the normalization of these parameters in the management of CKD-MBD, mainly due to the impact of this approach on the survival of patients on hemodialysis.

CONCLUSION

We concluded that the correlations between the laboratory components of CKD-MBD and the clinical, anthropometric and laboratory characteristics studied were, in many aspects, strongly representative correlations, showing that in clinical practice many aspects found may contribute to a better understanding of the individual profile of this specific population.

Acknowledgments

Fundação de Amparo à Pesquisa e Inovação do Espírito Santo (FAPES) Fundação de Apoio à Pesquisa e Inovação do Espírito Santo. UFES – Universidade Federal do Espírito Santo. Name of funding agency: Fundação de Amparo à Pesquisa e Inovação do Espírito Santo (FAPES) n° 35081,543,19306,18042018, Aviso nº, 03/2018-Programa de Pesquisa para o SUS (PPSUS), City: Vitória, State: Espírito Santo, Brasil.

REFERENCES

1 Streja E, Wang HY, Lau WL, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K, et al. Mortality of Combined Serum Phosphorus and Parathyroid Hormone Concentrations and their Changes over Time in Hemodialysis Patients. Bone. 2014; 61: 201–207. DOI:https://doi.org/10.1016/j.bone.2014.01.016.Links ]

2 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009;76:S1–130. https://doi.org/10.1038/ki.2009.188.Links ]

3 Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 2024;105:S117–314. https://doi.org/10.1016/j.kint.2023.10.018.Links ]

4 Yamada S, Tsuruya K, Kitazono T, Nakano T. Emerging cross-talks between chronic kidney disease- mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis. Clin Exp Nephrol 2022;26:613–29. https://doi.org/10.1007/s10157-022-02216-x.Links ]

5 Cernaro V, Longhitano E, Calabrese V, Casuscelli C, Di Carlo S, Spinella C, et al. Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure. Expert Opin Pharmacother 2023;24:1737–46. https://doi.org/10.1080/14656566.2023.2243817.Links ]

6 Sembajwe FL, Namaganda A, Nfambi J, Muwonge H, Katamba G, Nakato R, et al. Dietary intake, body composition and micronutrient profile of patients on maintenance hemodialysis attending Kiruddu National Referral Hospital, Uganda: A cross sectional study. PLoS One 2023;18:e0291813. https://doi.org/10.1371/journal.pone.0291813.Links ]

7 Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 2015;30:1542–51. https://doi.org/10.1093/ndt/gfv099.Links ]

8 Marcelli D, Usvyat LA, Kotanko P, Bayh I, Canaud B, Etter M, et al. Body Composition and Survival in Dialysis Patients: Results from an International Cohort Study. Clinical Journal of the American Society of Nephrology 2015;10:1192–200. https://doi.org/10.2215/CJN.08550814.Links ]

9 Hussain I, Tandi R, Singh G, Kaur G, Abhishek, Dodda S, et al. Correlation of FGF-23 with biochemical markers and bone density in chronic kidney disease-bone mineral density disorder. Cureus 2023;15:e33879. https://doi.org/10.7759/cureus.33879.Links ]

10 Lopes MB, Karaboyas A, Bieber B, Pisoni RL, Walpen S, Fukagawa M, et al. Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS. Nephrol Dial Transplant 2020;35:1794–801. https://doi.org/10.1093/ndt/gfaa054.Links ]

11 Wu G, Li L, Wu Z. A meta-analysis of randomized controlled trials of tonifying kidney and strengthen bone therapy on nondialysis patients with chronic kidney disease-mineral and bone disorder. Medicine (Baltimore) 2023;102:e34044. https://doi.org/10.1097/MD.0000000000034044.Links ]

12 Kir S, Komaba H, Garcia AP, Economopoulos KP, Liu W, Lanske B, et al. PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Cell Metab 2016;23:315–23. https://doi.org/10.1016/j.cmet.2015.11.003.Links ]

13 Cordeiro A, Santos A, Bernardes M, Ramalho A, Martins MJ. Vitamin D metabolism in human adipose tissue: could it explain low vitamin D status in obesity? Horm Mol Biol Clin Investig 2017;33. https://doi.org/10.1515/hmbci-2017-0003.Links ]

14 Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208–18. https://doi.org/10.1097/01.ASN.0000133041.27682.A2.Links ]

15 Barreto MA, Cattafesta M, Cunha AC da, Paixão MPCP, Neto ET dos S, Salaroli LB. Relationship between quality of life and sociodemographic, clinical and lifestyle characteristics of patients undergoing hemodialysis. J Hum Growth Dev 2023;33:444–69. https://doi.org/10.36311/jhgd.v33.15422.Links ]

16 Lohman TG, Roche AF. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics; 1988. 39–54 p. [ Links ]

17 WHO. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i – xii, 1–253. [ Links ]

18 Lameu EB, Gerude MF, Corrêa RC, Lima KA. Adductor pollicis muscle: a new anthropometric parameter. Rev Hosp Clin Fac Med Sao Paulo 2004;59:57–62. https://doi.org/10.1590/s0041-87812004000200002.Links ]

19 Bragagnolo R, Caporossi FS, Dock-Nascimento DB, de Aguilar-Nascimento JE. Espessura do músculo adutor do polegar: um método rápido e confiável na avaliação nutricional de pacientes cirúrgicos. Rev Col Bras Cir 2009;36:371–6. https://doi.org/10.1590/s0100-69912009000500003.Links ]

20 Frisancho AR. Anthropometric standards for the assessment of growth and nutritional status. Ann Arbor, MI: University of Michigan Press; 1990. 189 p. https://doi.org/10.3998/mpub.12198.Links ]

21 Jamal SA, Leiter RE, Jassal V, Hamilton CJ, Bauer DC. Impaired muscle strength is associated with fractures in hemodialysis patients. Osteoporos Int 2006;17:1390–7. https://doi.org/10.1007/s00198-006-0133-y.Links ]

22 Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–23. https://doi.org/10.1093/ageing/afq034.Links ]

23 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011) 2017;7:1–59. https://doi.org/10.1016/j.kisu.2017.04.001.Links ]

24 Martins R. Nutrição e o Rim Capa comum – 10 abril 2013. 2nd ed. Guanabara Koogan; 2013. [ Links ]

25 Péterle VB, Souza J de O, Busato F de O, Eutrópio FJ, da Costa G de AP, Olivieri DN, et al. Clinical and hematological data to group different chronic kidney disease patients: A practical approach to establish different groups of patients. J Clin Lab Anal 2018;32:e22377. https://doi.org/10.1002/jcla.22377.Links ]

26 Du J, Wang S, Yu W, Li S, Xu J. Analysis of the parathyroid function in maintenance hemodialysis patients from Changchun, China. Chronic Dis Transl Med 2017;3:181–5. https://doi.org/10.1016/j.cdtm.2017.07.001.Links ]

27 Rodelo-Haad C, Rodríguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, Agüera ML, Muñoz- Castañeda JR, et al. Phosphate control in reducing FGF23 levels in hemodialysis patients. PLoS One 2018;13:e0201537. https://doi.org/10.1371/journal.pone.0201537.Links ]

28 Luis D, Zlatkis K, Comenge B, García Z, Navarro JF, Lorenzo V, et al. Dietary quality and adherence to dietary recommendations in patients undergoing hemodialysis. J Ren Nutr 2016;26:190–5. https://doi.org/10.1053/j.jrn.2015.11.004.Links ]

29 Clark-Cutaia MN, Sevick MA, Thurheimer-Cacciotti J, Hoffman LA, Snetselaar L, Burke LE, et al. Perceived barriers to adherence to hemodialysis dietary recommendations. Clin Nurs Res 2019;28:1009–29. https://doi.org/10.1177/1054773818773364.Links ]

30 Zanandreia M, Cattafesta M, Martins CA, Paixão MPCP, Soares FLP, Peterle FZ, et al. Socioeconomic, clinical and nutritional factors on interdialytic weight gain in haemodialysis users. Acta Paul Enferm 2024;37:eAPE02062. https://doi.org/10.37689/acta-ape/2024ao00020622.Links ]

31 Kang SH, Do JY, Cho J-H, Jeong HY, Yang DH, Kim JC. Association between vitamin D level and muscle strength in patients undergoing hemodialysis. Kidney Blood Press Res 2020;45:419–30. https://doi.org/10.1159/000506986.Links ]

32 Bataille S, Landrier J-F, Astier J, Giaime P, Sampol J, Sichez H, et al. The “dose-effect” relationship between 25-hydroxyvitamin D and muscle strength in hemodialysis patients favors a normal threshold of 30 ng/mL for plasma 25-hydroxyvitamin D. J Ren Nutr 2016;26:45–52. https://doi.org/10.1053/j.jrn.2015.08.007.Links ]

33 Pereira RA, Caetano AL, Cuppari L, Kamimura MA. Adductor pollicis muscle thickness as a predictor of handgrip strength in hemodialysis patients. J Bras Nefrol 2013;35:177–84. https://doi.org/10.5935/0101-2800.20130029.Links ]

34 de Oliveira CMC, Kubrusly M, Mota RS, Choukroun G, Neto JB, da Silva CAB. Adductor pollicis muscle thickness: a promising anthropometric parameter for patients with chronic renal failure. J Ren Nutr 2012;22:307–16. https://doi.org/10.1053/j.jrn.2011.07.006.Links ]

35 Martins CA, Ferreira JRS, Cattafesta M, Neto ETDS, Rocha JLM, Salaroli LB. Cut points of the conicity index as an indicator of abdominal obesity in individuals undergoing hemodialysis: An analysis of latent classes. Nutrition 2023;106:111890. https://doi.org/10.1016/j.nut.2022.111890.Links ]

36 Patriota P, Rezzi S, Guessous I, Marques-Vidal P. Association between anthropometric markers of adiposity, adipokines and vitamin D levels. Sci Rep 2022;12:15435. https://doi.org/10.1038/s41598-022-19409-9.Links ]

37 De Pergola G, Martino T, Zupo R, Caccavo D, Pecorella C, Paradiso S, et al. 25 hydroxyvitamin D levels are negatively and independently associated with Fat Mass in a cohort of healthy overweight and obese subjects. Endocr Metab Immune Disord Drug Targets 2019;19:838–44. https://doi.org/10.2174/1871530319666190122094039.Links ]

38 Ahmadi F, Damghani S, Lessan-Pezeshki M, Razeghi E, Maziar S, Mahdavi-Mazdeh M. Association of low vitamin D levels with metabolic syndrome in hemodialysis patients: Metabolic syndrome in hemodialysis. Hemodial Int 2016;20:261–9. https://doi.org/10.1111/hdi.12316.Links ]

39 Gotch F, Levin NW, Kotanko P. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif 2010;29:163–76. https://doi.org/10.1159/000245924.Links ]

Received: May 01, 2024; Accepted: September 01, 2024; Published: November 01, 2024

Corresponding author lucianebresciani@gmail.com

Conflicts of interest

there is no conflict of interest.

Creative Commons License this article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.